product summary
Loading...
company name : 
Tocris Bioscience
product type : 
chemical
product name : 
Thalidomide 4'-ether-alkylC4-amine
catalog : 
6917
quantity : 
25 mg
price : 
203 USD
more info or order : 
product information
brand : 
Tocris
master code : 
6917
SKU : 
6917/25
product name : 
Thalidomide 4'-ether-alkylC4-amine
description : 
Cereblon ligand with alkyl linker and terminal amine for onward chemistry
target : 
Degrader Building Blocks
category : 
Small Molecules
unit size : 
25 mg
purity : 
95%
observed molecular weight : 
381.81
url print : 
?utm_source=distributor&utm_medium=referral&utm_campaign=product&utm_term=smallmolecules
details of functionality : 
Functionalized cereblon ligand for PROTAC research and development; incorporates an E3 ligase ligand plus an alkyl linker with a terminal amine ready for conjugation to a target protein ligand. Part of a range of functionalized tool molecules for PROTAC R D. .  This product has been recently renamed. The previous name for this product was Thalidomide - linker 9  .  PROTAC  is a registered trademark of Arvinas Operations, Inc., and is used under license.
catalog number base : 
6917
product keywords : 
functionalized PROTAC cereblon E3 ubiquitin ligase alkyl linker conjugate targeted protein degradation TPD 1957235-96-9 building blocks components Thalidomide - linker 9 Cereblon Ligands Plus Linkers 6917,
extended description : 
Cereblon ligand with alkyl linker and terminal amine for onward chemistry
chemical name text : 
4-(4-Aminobutoxy)-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione hydrochloride
formula : 
C 17 H 19 N 3 O 5 .HCl
formula text : 
C17H19N3O5.HCl
cas num : 
2376990-29-1
2020 USD : 
199
2021 USD : 
203 USD
alt names : 
Thalidomide - linker 9
storage : 
Store at -20°C
more info or order : 
company information

Tocris Bioscience
The Watkins Building
Atlantic Road
Avonmouth, Bristol
BS11 9QD
Atlantic Road
Avonmouth, Bristol
BS11 9QD
info@bio-techne.com
https://www.tocris.com800-343-7475
headquarters: UK
browse more products
questions and comments
